Cargando…
The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
Emerging preclinical or clinical evidence suggests a vital role of nuclear receptor-mediated signals in modulating urothelial carcinogenesis and cancer growth. These include, but are not limited to, androgen receptor, estrogen receptors, glucocorticoid receptor, progesterone receptor, vitamin D rece...
Autores principales: | Nagata, Yujiro, Miyamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798270/ https://www.ncbi.nlm.nih.gov/pubmed/35117270 http://dx.doi.org/10.21037/tcr.2020.01.06 |
Ejemplares similares
-
Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020) -
The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020) -
Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020) -
Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
por: Ko, Young Hwii
Publicado: (2020) -
Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
por: Choi, Hoon, et al.
Publicado: (2020)